XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 82 filers reported holding XENON PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,723,371 | -17.6% | 255,368 | -7.2% | 0.00% | 0.0% |
| Q2 2023 | $10,590,580 | +3.7% | 275,080 | -3.6% | 0.00% | 0.0% |
| Q1 2023 | $10,215,289 | -8.6% | 285,423 | +0.7% | 0.00% | -33.3% |
| Q4 2022 | $11,180,022 | -33.4% | 283,541 | -39.1% | 0.00% | -25.0% |
| Q3 2022 | $16,796,000 | +86.3% | 465,265 | +57.0% | 0.00% | +100.0% |
| Q2 2022 | $9,014,000 | -59.3% | 296,314 | -59.1% | 0.00% | -60.0% |
| Q1 2022 | $22,143,000 | +313.6% | 724,337 | +322.6% | 0.01% | +400.0% |
| Q4 2021 | $5,354,000 | +265.0% | 171,394 | +78.6% | 0.00% | – |
| Q3 2021 | $1,467,000 | -48.2% | 95,985 | -36.9% | 0.00% | -100.0% |
| Q2 2021 | $2,834,000 | +17.1% | 152,218 | +12.6% | 0.00% | 0.0% |
| Q1 2021 | $2,420,000 | +14.0% | 135,219 | -2.0% | 0.00% | 0.0% |
| Q4 2020 | $2,122,000 | +209.3% | 137,961 | +122.6% | 0.00% | – |
| Q3 2020 | $686,000 | +86.9% | 61,966 | +111.7% | 0.00% | – |
| Q2 2020 | $367,000 | +115.9% | 29,272 | +126.3% | 0.00% | – |
| Q4 2019 | $170,000 | +78.9% | 12,937 | +22.9% | 0.00% | – |
| Q3 2019 | $95,000 | -23.4% | 10,529 | -14.0% | 0.00% | – |
| Q1 2019 | $124,000 | +55.0% | 12,246 | -3.3% | 0.00% | – |
| Q4 2018 | $80,000 | -60.4% | 12,663 | +5.5% | 0.00% | – |
| Q1 2015 | $202,000 | -50.9% | 11,999 | -42.3% | 0.00% | – |
| Q4 2014 | $411,000 | – | 20,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |